Sabourin LA, Rudnicki MA: The molecular regulation of myogenesis. Clin Genet. 2000, 57: 16-25.
Le Grand F, Rudnicki MA: Skeletal muscle satellite cells and adult myogenesis. Curr Opin Cell Biol. 2007, 19: 628-633. 10.1016/j.ceb.2007.09.012.
Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S: The protein kinase complement of the human genome. Science. 2002, 298: 1912-1934. 10.1126/science.1075762.
Caenepeel S, Charydczak G, Sudarsanam S, Hunter T, Manning G: The mouse kinome: discovery and comparative genomics of all mouse protein kinases. Proc Natl Acad Sci USA. 2004, 101: 11707-11712. 10.1073/pnas.0306880101.
Walsh DA, Perkins JP, Krebs EG: An adenosine 3',5'-monophosphate-dependant protein kinase from rabbit skeletal muscle. J Biol Chem. 1968, 243: 3763-3765.
Shabb JB: Physiological substrates of cAMP-dependent protein kinase. Chem Rev. 2001, 101: 2381-2411. 10.1021/cr000236l.
Chen AE, Ginty DD, Fan CM: Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins. Nature. 2005, 433: 317-322. 10.1038/nature03126.
Li L, Heller-Harrison R, Czech M, Olson EN: Cyclic AMP-dependent protein kinase inhibits the activity of myogenic helix-loop-helix proteins. Mol Cell Biol. 1992, 12: 4478-4485.
Winter B, Braun T, Arnold HH: cAMP-dependent protein kinase represses myogenic differentiation and the activity of the muscle-specific helix-loop-helix transcription factors Myf-5 and MyoD. J Biol Chem. 1993, 268: 9869-9878.
Du M, Perry RLS, Nowacki NB, Gordon JW, Salma J, Zhao J, Aziz A, Chan J, Siu KWM, McDermott JC: Protein kinase A represses skeletal myogenesis by targeting myocyte enhancer factor 2D. Mol Cell Biol. 2008, 28: 2952-2970. 10.1128/MCB.00248-08.
Siow NL, Choi RCY, Cheng AWM, Jiang JXS, Wan DCC, Zhu SQ, Tsim KWK: A cyclic AMP-dependent pathway regulates the expression of acetylcholinesterase during myogenic differentiation of C2C12 cells. J Biol Chem. 2002, 277: 36129-36136. 10.1074/jbc.M206498200.
Hu JS, Olson EN: Regulation of differentiation of the BC3H1 muscle cell line through cAMP-dependent and -independent pathways. J Biol Chem. 1988, 263: 19670-19677.
Salminen A, Braun T, Buchberger A, Jürs S, Winter B, Arnold HH: Transcription of the muscle regulatory gene MYF4 is regulated by serum components, peptide growth factors and signaling pathways involving G proteins. J Cell Biol. 1991, 115: 905-917. 10.1083/jcb.115.4.905.
De Arcangelis V, Coletti D, Conti M, Lagarde M, Molinaro M, Adamo S, Nemoz G, Naro F: IGF-I-induced differentiation of L6 myogenic cells requires the activity of cAMP-phosphodiesterase. Mol Biol Cell. 2003, 14: 1392-1404. 10.1091/mbc.E02-03-0156.
Mukai A, Hashimoto N: Localized cyclic AMP-dependent protein kinase activity is required for myogenic cell fusion. Exp Cell Res. 2008, 314: 387-397. 10.1016/j.yexcr.2007.10.006.
Rogers JE, Narindrasorasak S, Cates GA, Sanwal BD: Regulation of protein kinase and its regulatory subunits during skeletal myogenesis. J Biol Chem. 1985, 260: 8002-8007.
Lorimer IA, Sanwal BD: Regulation of cyclic AMP-dependent protein kinase levels during skeletal myogenesis. Biochem J. 1989, 264: 305-308.
Murray AW: Recycling the cell cycle: cyclins revisited. Cell. 2004, 116: 221-234. 10.1016/S0092-8674(03)01080-8.
Rao SS, Chu C, Kohtz DS: Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol Cell Biol. 1994, 14: 5259-5267.
Skapek SX, Rhee J, Spicer DB, Lassar AB: Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science. 1995, 267: 1022-1024. 10.1126/science.7863328.
Rao SS, Kohtz DS: Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor β: a role for cyclin D1 in control of myoblast differentiation. J Biol Chem. 1995, 270: 4093-4100. 10.1074/jbc.270.8.4093.
Skapek SX, Rhee J, Kim PS, Novitch BG, Lassar AB: Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation. Mol Cell Biol. 1996, 16: 7043-7053.
Guo K, Walsh K: Inhibition of myogenesis by multiple cyclin-Cdk complexes: coordinate regulation of myogenesis and cell cycle activity at the level of E2F. J Biol Chem. 1997, 272: 791-797. 10.1074/jbc.272.2.791.
Saab R, Bills JL, Miceli AP, Anderson CM, Khoury JD, Fry DW, Navid F, Houghton PJ, Skapek SX: Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cells. Mol Cancer Ther. 2006, 5: 1299-1308. 10.1158/1535-7163.MCT-05-0383.
Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B: Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell. 1993, 72: 309-324. 10.1016/0092-8674(93)90110-C.
Kitzmann M, Vandromme M, Schaeffer V, Carnac G, Labbé JC, Lamb N, Fernandez A: cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity. Mol Cell Biol. 1999, 19: 3167-3176.
Reynaud EG, Pelpel K, Guillier M, Leibovitch MP, Leibovitch SA: p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts. Mol Cell Biol. 1999, 19: 7621-7629.
Tintignac LA, Leibovitch MP, Kitzmann M, Fernandez A, Ducommun B, Meijer L, Leibovitch SA: Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells. Exp Cell Res. 2000, 259: 300-307. 10.1006/excr.2000.4973.
Song A, Wang Q, Goebl MG, Harrington MA: Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol Cell Biol. 1998, 18: 4994-4999.
Zhang JM, Wei Q, Zhao X, Paterson BM: Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4. EMBO J. 1999, 18: 926-933. 10.1093/emboj/18.4.926.
Lazaro JB, Bailey PJ, Lassar AB: Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation. Genes Dev. 2002, 16: 1792-1805. 10.1101/gad.U-9988R.
Jahn L, Sadoshima J, Izumo S: Cyclins and cyclin-dependent kinases are differentially regulated during terminal differentiation of C2C12 muscle cells. Exp Cell Res. 1994, 212: 297-307. 10.1006/excr.1994.1147.
Guo K, Wang J, Andrés V, Smith RC, Walsh K: MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol. 1995, 15: 3823-3829.
Wang J, Nadal-Ginard B: Regulation of cyclins and p34CDC2 expression during terminal differentiation of C2C12 myocytes. Biochem Biophys Res Commun. 1995, 206: 82-88. 10.1006/bbrc.1995.1012.
Franklin DS, Xiong Y: Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation. Mol Biol Cell. 1996, 7: 1587-1599.
Wang J, Walsh K: Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin-dependent kinase 4 complex. Cell Growth Differ. 1996, 7: 1471-1478.
Tedesco D, Baron L, Fischer-Fantuzzi L, Vesco C: Induction of cyclins E and A in response to mitogen removal: a basic alteration associated with the arrest of differentiation of C2 myoblasts transformed by simian virus 40 large T antigen. J Virol. 1997, 71: 2217-2224.
Knudsen ES, Pazzagli C, Born TL, Bertolaet BL, Knudsen KE, Arden KC, Henry RR, Feramisco JR: Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD. Cancer Res. 1998, 58: 2042-2049.
Chu CY, Lim RW: Involvement of p27kip1 and cyclin D3 in the regulation of cdk2 activity during skeletal muscle differentiation. Biochim Biophys Acta. 2000, 1497: 175-185. 10.1016/S0167-4889(00)00064-1.
Latella L, Sacco A, Pajalunga D, Tiainen M, Macera D, D'Angelo M, Felici A, Sacchi A, Crescenzi M: Reconstitution of cyclin D1-associated kinase activity drives terminally differentiated cells into the cell cycle. Mol Cell Biol. 2001, 21: 5631-5643. 10.1128/MCB.21.16.5631-5643.2001.
Peschiaroli A, Figliola R, Coltella L, Strom A, Valentini A, D'Agnano I, Maione R: MyoD induces apoptosis in the absence of RB function through a p21WAF1-dependent re-localization of cyclin/cdk complexes to the nucleus. Oncogene. 2002, 21: 8114-8127. 10.1038/sj.onc.1206010.
Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB: Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science. 1995, 267: 1018-1021. 10.1126/science.7863327.
Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW, Elledge SJ: p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science. 1995, 267: 1024-1027. 10.1126/science.7863329.
Wang J, Walsh K: Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science. 1996, 273: 359-361. 10.1126/science.273.5273.359.
Puri PL, Balsano C, Burgio VL, Chirillo P, Natoli G, Ricci L, Mattei E, Graessmann A, Levrero M: MyoD prevents cyclin A/cdk2 containing E2F complexes formation in terminally differentiated myocytes. Oncogene. 1997, 14: 1171-1184. 10.1038/sj.onc.1200941.
Phelps DE, Hsiao KM, Li Y, Hu N, Franklin DS, Westphal E, Lee EYHP, Xiong Y: Coupled transcriptional and translational control of cyclin-dependent kinase inhibitor p18INK4c expression during myogenesis. Mol Cell Biol. 1998, 18: 2334-2343.
Zabludoff SD, Csete M, Wagner R, Yu X, Wold BJ: p27Kip1 is expressed transiently in developing myotomes and enhances myogenesis. Cell Growth Differ. 1998, 9: 1-11.
Zhang P, Wong C, Liu D, Finegold M, Harper JW, Elledge SJ: p21CIP1 and p57KIP2 control muscle differentiation at the myogenin step. Genes Dev. 1999, 13: 213-224. 10.1101/gad.13.2.213.
Kiess M, Gill RM, Hamel PA: Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene. 1995, 10: 159-166.
Lazaro JB, Kitzmann M, Poul MA, Vandromme M, Lamb NJ, Fernandez A: Cyclin dependent kinase 5, cdk5, is a positive regulator of myogenesis in mouse C2 cells. J Cell Sci. 1997, 110: 1251-1260.
Sahlgren CM, Mikhailov A, Vaittinen S, Pallari HM, Kalimo H, Pant HC, Eriksson JE: Cdk5 regulates the organization of Nestin and its association with p35. Mol Cell Biol. 2003, 23: 5090-5106. 10.1128/MCB.23.14.5090-5106.2003.
Sarker KP, Lee KY: L6 myoblast differentiation is modulated by Cdk5 via the PI3K-AKT-p70S6K signaling pathway. Oncogene. 2004, 23: 6064-6070. 10.1038/sj.onc.1207819.
de Thonel A, Ferraris SE, Pallari HM, Imanishi SY, Kochin V, Hosokawa T, Hisanaga S, Sahlgren C, Eriksson JE: Protein kinase Cζ regulates Cdk5/p25 signaling during myogenesis. Mol Biol Cell. 2010, 21: 1423-1434. 10.1091/mbc.E09-10-0847.
Pallari HM, Lindqvist J, Torvaldson E, Ferraris SE, He T, Sahlgren C, Eriksson JE: Nestin as a regulator of Cdk5 in differentiating myoblasts. Mol Biol Cell. 2011, 22: 1539-1549. 10.1091/mbc.E10-07-0568.
Simone C, Stiegler P, Bagella L, Pucci B, Bellan C, De Falco G, De Luca A, Guanti G, Puri PL, Giordano A: Activation of MyoD-dependent transcription by cdk9/cyclin T2. Oncogene. 2002, 21: 4137-4148. 10.1038/sj.onc.1205493.
Giacinti C, Bagella L, Puri PL, Giordano A, Simone C: MyoD recruits the cdk9/cyclin T2 complex on myogenic-genes regulatory regions. J Cell Physiol. 2006, 206: 807-813. 10.1002/jcp.20523.
Giacinti C, Musarò A, De Falco G, Jourdan I, Molinaro M, Bagella L, Simone C, Giordano A: Cdk9-55: a new player in muscle regeneration. J Cell Physiol. 2008, 216: 576-582. 10.1002/jcp.21361.
Ray LB, Sturgill TW: Rapid stimulation by insulin of a serine/threonine kinase in 3T3-L1 adipocytes that phosphorylates microtubule-associated protein 2 in vitro. Proc Natl Acad Sci USA. 1987, 84: 1502-1506. 10.1073/pnas.84.6.1502.
Boulton TG, Yancopoulos GD, Gregory JS, Slaughter C, Moomaw C, Hsu J, Cobb MH: An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control. Science. 1990, 249: 64-67. 10.1126/science.2164259.
Reed SA, Ouellette SE, Liu X, Allen RE, Johnson SE: E2F5 and LEK1 translocation to the nucleus is an early event demarcating myoblast quiescence. J Cell Biochem. 2007, 101: 1394-1408. 10.1002/jcb.21256.
Volonte D, Liu Y, Galbiati F: The modulation of caveolin-1 expression controls satellite cell activation during muscle repair. FASEB J. 2005, 19: 237-239.
Kook SH, Son YO, Choi KC, Lee HJ, Chung WT, Hwang IH, Lee JC: Cyclic mechanical stress suppresses myogenic differentiation of adult bovine satellite cells through activation of extracellular signal-regulated kinase. Mol Cell Biochem. 2008, 309: 133-141. 10.1007/s11010-007-9651-y.
Jahn L, Sadoshima J, Izumo S: Cyclins and cyclin-dependent kinases are differentially regulated during terminal differentiation of C2C12 muscle cells. Exp Cell Res. 1994, 212: 297-307. 10.1006/excr.1994.1147.
Miralles F, Ron D, Baiget M, Félez J, Muñoz-Cánoves P: Differential regulation of urokinase-type plasminogen activator expression by basic fibroblast growth factor and serum in myogenesis: requirement of a common mitogen-activated protein kinase pathway. J Biol Chem. 1998, 273: 2052-2058. 10.1074/jbc.273.4.2052.
Pizon V, Baldacci G: Rap1A protein interferes with various MAP kinase activating pathways in skeletal myogenic cells. Oncogene. 2000, 19: 6074-6081. 10.1038/sj.onc.1203984.
Adi S, Bin-Abbas B, Wu NY, Rosenthal SM: Early stimulation and late inhibition of extracellular signal-regulated kinase 1/2 phosphorylation by IGF-I: a potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation. Endocrinology. 2002, 143: 511-516. 10.1210/en.143.2.511.
Milasincic DJ, Calera MR, Farmer SR, Pilch PF: Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways. Mol Cell Biol. 1996, 16: 5964-5973.
Kudla AJ, Jones NC, Rosenthal RS, Arthur K, Clase KL, Olwin BB: The FGF receptor-1 tyrosine kinase domain regulates myogenesis but is not sufficient to stimulate proliferation. J Cell Biol. 1998, 142: 241-250. 10.1083/jcb.142.1.241.
Jones NC, Fedorov YV, Rosenthal RS, Olwin BB: ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. J Cell Physiol. 2001, 186: 104-115. 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0.
Tortorella LL, Milasincic DJ, Pilch PF: Critical proliferation-independent window for basic fibroblast growth factor repression of myogenesis via the p42/p44 MAPK signaling pathway. J Biol Chem. 2001, 276: 13709-13717.
Nagata Y, Honda Y, Matsuda R: FGF2 induces ERK phosphorylation through Grb2 and PKC during quiescent myogenic cell activation. Cell Struct Funct. 2010, 35: 63-71. 10.1247/csf.09024.
Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR: The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem. 1997, 272: 6653-6662. 10.1074/jbc.272.10.6653.
Lawlor MA, Feng X, Everding DR, Sieger K, Stewart CE, Rotwein P: Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways. Mol Cell Biol. 2000, 20: 3256-3265. 10.1128/MCB.20.9.3256-3265.2000.
Chakravarthy MV, Abraha TW, Schwartz RJ, Fiorotto ML, Booth FW: Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3'-kinase/Akt signaling pathway. J Biol Chem. 2000, 275: 35942-35952. 10.1074/jbc.M005832200.
Jo C, Kim H, Jo I, Choi I, Jung SC, Kim J, Kim SS, Jo SA: Leukemia inhibitory factor blocks early differentiation of skeletal muscle cells by activating ERK. Biochim Biophys Acta. 2005, 1743: 187-197. 10.1016/j.bbamcr.2004.11.002.
Kudla AJ, John ML, Bowen-Pope DF, Rainish B, Olwin BB: A requirement for fibroblast growth factor in regulation of skeletal muscle growth and differentiation cannot be replaced by activation of platelet-derived growth factor signaling pathways. Mol Cell Biol. 1995, 15: 3238-3246.
Li J, Johnson SE: ERK2 is required for efficient terminal differentiation of skeletal myoblasts. Biochem Biophys Res Commun. 2006, 345: 1425-1433. 10.1016/j.bbrc.2006.05.051.
Heller H, Gredinger E, Bengal E: Rac1 inhibits myogenic differentiation by preventing the complete withdrawal of myoblasts from the cell cycle. J Biol Chem. 2001, 276: 37307-37316. 10.1074/jbc.M103195200.
Lathrop B, Thomas K, Glaser L: Control of myogenic differentiation by fibroblast growth factor is mediated by position in the G1 phase of the cell cycle. J Cell Biol. 1985, 101: 2194-2198. 10.1083/jcb.101.6.2194.
Weyman CM, Ramocki MB, Taparowsky EJ, Wolfman A: Distinct signaling pathways regulate transformation and inhibition of skeletal muscle differentiation by oncogenic Ras. Oncogene. 1997, 14: 697-704. 10.1038/sj.onc.1200874.
Samuel DS, Ewton DZ, Coolican SA, Petley TD, McWade FJ, Florini JR: Raf-1 activation stimulates proliferation and inhibits IGF-stimulated differentiation in L6A1 myoblasts. Horm Metab Res. 1999, 31: 55-64. 10.1055/s-2007-978699.
Campbell JS, Wenderoth MP, Hauschka SD, Krebs EG: Differential activation of mitogen-activated protein kinase in response to basic fibroblast growth factor in skeletal muscle cells. Proc Natl Acad Sci USA. 1995, 92: 870-874. 10.1073/pnas.92.3.870.
Spizz G, Roman D, Strauss A, Olson EN: Serum and fibroblast growth factor inhibit myogenic differentiation through a mechanism dependent on protein synthesis and independent of cell proliferation. J Biol Chem. 1986, 261: 9483-9488.
Clegg CH, Linkhart TA, Olwin BB, Hauschka SD: Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J Cell Biol. 1987, 105: 949-956. 10.1083/jcb.105.2.949.
Vaidya TB, Rhodes SJ, Taparowsky EJ, Konieczny SF: Fibroblast growth factor and transforming growth factor β repress transcription of the myogenic regulatory gene MyoD1. Mol Cell Biol. 1989, 9: 3576-3579.
Yoshida S, Fujisawa-Sehara A, Taki T, Arai K, Nabeshima Y: Lysophosphatidic acid and bFGF control different modes in proliferating myoblasts. J Cell Biol. 1996, 132: 181-193. 10.1083/jcb.132.1.181.
Montarras D, Aurade F, Johnson T, Ilan J, Gros F, Pinset C: Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive control between insulin-like growth factor II and MyoD, operating as early as at the myoblast stage. J Cell Sci. 1996, 109: 551-560.
Weyman CM, Wolfman A: Mitogen-activated protein kinase kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2. Endocrinology. 1998, 139: 1794-1800. 10.1210/en.139.4.1794.
Peña TL, Chen SH, Konieczny SF, Rane SG: Ras/MEK/ERK up-regulation of the fibroblast KCa channel FIK is a common mechanism for basic fibroblast growth factor and transforming growth factor-β suppression of myogenesis. J Biol Chem. 2000, 275: 13677-13682. 10.1074/jbc.275.18.13677.
Olson EN, Spizz G, Tainsky MA: The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol Cell Biol. 1987, 7: 2104-2111.
Gossett LA, Zhang W, Olson EN: Dexamethasone-dependent inhibition of differentiation of C2 myoblasts bearing steroid-inducible N-ras oncogenes. J Cell Biol. 1988, 106: 2127-2137. 10.1083/jcb.106.6.2127.
Bennett AM, Tonks NK: Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science. 1997, 278: 1288-1291. 10.1126/science.278.5341.1288.
Sarbassov DD, Jones LG, Peterson CA: Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts. Mol Endocrinol. 1997, 11: 2038-2047. 10.1210/me.11.13.2038.
Rommel C, Clarke BA, Zimmermann S, Nuñez L, Rossman R, Reid K, Moelling K, Yancopoulos GD, Glass DJ: Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science. 1999, 286: 1738-1741. 10.1126/science.286.5445.1738.
Wu Z, Woodring PJ, Bhakta KS, Tamura K, Wen F, Feramisco JR, Karin M, Wang JY, Puri PL: p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol. 2000, 20: 3951-3964. 10.1128/MCB.20.11.3951-3964.2000.
Winter B, Arnold HH: Activated raf kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism. J Cell Sci. 2000, 113: 4211-4220.
Khurana A, Dey CS: Subtype specific roles of mitogen activated protein kinases in L6E9 skeletal muscle cell differentiation. Mol Cell Biochem. 2002, 238: 27-39. 10.1023/A:1019957602038.
Wang X, Thomson SR, Starkey JD, Page JL, Ealy AD, Johnson SE: Transforming growth factor β1 is up-regulated by activated Raf in skeletal myoblasts but does not contribute to the differentiation-defective phenotype. J Biol Chem. 2004, 279: 2528-2534.
Tiffin N, Adi S, Stokoe D, Wu NY, Rosenthal SM: Akt phosphorylation is not sufficient for insulin-like growth factor-stimulated myogenin expression but must be accompanied by down-regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation. Endocrinology. 2004, 145: 4991-4996. 10.1210/en.2004-0101.
Rossi S, Stoppani E, Puri PL, Fanzani A: Differentiation of human rhabdomyosarcoma RD cells is regulated by reciprocal, functional interactions between myostatin, p38 and extracellular regulated kinase signalling pathways. Eur J Cancer. 2011, 47: 1095-1105. 10.1016/j.ejca.2010.12.010.
Lassar AB, Thayer MJ, Overell RW, Weintraub H: Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1. Cell. 1989, 58: 659-667. 10.1016/0092-8674(89)90101-3.
Konieczny SF, Drobes BL, Menke SL, Taparowsky EJ: Inhibition of myogenic differentiation by the H-ras oncogene is associated with the down regulation of the MyoD1 gene. Oncogene. 1989, 4: 473-481.
Ramocki MB, Johnson SE, White MA, Ashendel CL, Konieczny SF, Taparowsky EJ: Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis. Mol Cell Biol. 1997, 17: 3547-3555.
Gredinger E, Gerber AN, Tamir Y, Tapscott SJ, Bengal E: Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells. J Biol Chem. 1998, 273: 10436-10444. 10.1074/jbc.273.17.10436.
Sternberg EA, Spizz G, Perry ME, Olson EN: A ras-dependent pathway abolishes activity of a muscle-specific enhancer upstream from the muscle creatine kinase gene. Mol Cell Biol. 1989, 9: 594-601.
Olwin BB, Hauschka SD: Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture. J Cell Biol. 1988, 107: 761-769. 10.1083/jcb.107.2.761.
Templeton TJ, Hauschka SD: FGF-mediated aspects of skeletal muscle growth and differentiation are controlled by a high affinity receptor, FGFR1. Dev Biol. 1992, 154: 169-181. 10.1016/0012-1606(92)90057-N.
Hamilton DL, Philp A, MacKenzie MG, Baar K: Prolonged activation of S6K1 does not suppress IRS or PI-3 kinase signaling during muscle cell differentiation. BMC Cell Biol. 2010, 11: 37-10.1186/1471-2121-11-37.
Sarbassov DD, Peterson CA: Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation. Mol Endocrinol. 1998, 12: 1870-1878. 10.1210/me.12.12.1870.
Ostrovsky O, Bengal E: The mitogen-activated protein kinase cascade promotes myoblast cell survival by stabilizing the cyclin-dependent kinase inhibitor, p21WAF1 protein. J Biol Chem. 2003, 278: 21221-21231. 10.1074/jbc.M211357200.
Cho YY, Yao K, Bode AM, Bergen HR, Madden BJ, Oh SM, Ermakova S, Kang BS, Choi HS, Shim JH, Dong Z: RSK2 mediates muscle cell differentiation through regulation of NFAT3. J Biol Chem. 2007, 282: 8380-8392. 10.1074/jbc.M611322200.
Han J, Lee JD, Bibbs L, Ulevitch RJ: A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 1994, 265: 808-811. 10.1126/science.7914033.
Freshney NW, Rawlinson L, Guesdon F, Jones E, Cowley S, Hsuan J, Saklatvala J: Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell. 1994, 78: 1039-1049. 10.1016/0092-8674(94)90278-X.
Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, Hunt T, Nebreda AR: A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 1994, 78: 1027-1037. 10.1016/0092-8674(94)90277-1.
Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 1994, 372: 739-746. 10.1038/372739a0.
Nagata Y, Takahashi N, Davis RJ, Todokoro K: Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood. 1998, 92: 1859-1869.
Morooka T, Nishida E: Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells. J Biol Chem. 1998, 273: 24285-24288. 10.1074/jbc.273.38.24285.
Engelman JA, Lisanti MP, Scherer PE: Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J Biol Chem. 1998, 273: 32111-32120. 10.1074/jbc.273.48.32111.
Hu Y, Chan E, Wang SX, Li B: Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation. Endocrinology. 2003, 144: 2068-2074. 10.1210/en.2002-220863.
Stanton LA, Sabari S, Sampaio AV, Underhill TM, Beier F: p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation. Biochem J. 2004, 378: 53-62. 10.1042/BJ20030874.
Bhat NR, Zhang P, Mohanty SB: p38 MAP kinase regulation of oligodendrocyte differentiation with CREB as a potential target. Neurochem Res. 2007, 32: 293-302. 10.1007/s11064-006-9274-9.
Cuenda A, Cohen P: Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J Biol Chem. 1999, 274: 4341-4346. 10.1074/jbc.274.7.4341.
Zetser A, Gredinger E, Bengal E: p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation: participation of the Mef2c transcription factor. J Biol Chem. 1999, 274: 5193-5200. 10.1074/jbc.274.8.5193.
Galbiati F, Volonte D, Engelman JA, Scherer PE, Lisanti MP: Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts: transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. J Biol Chem. 1999, 274: 30315-30321. 10.1074/jbc.274.42.30315.
Li Y, Jiang B, Ensign WY, Vogt PK, Han J: Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase. Cell Signal. 2000, 12: 751-757. 10.1016/S0898-6568(00)00120-0.
de Angelis L, Zhao J, Andreucci JJ, Olson EN, Cossu G, McDermott JC: Regulation of vertebrate myotome development by the p38 MAP kinase-MEF2 signaling pathway. Dev Biol. 2005, 283: 171-179. 10.1016/j.ydbio.2005.04.009.
Perdiguero E, Ruiz-Bonilla V, Gresh L, Hui L, Ballestar E, Sousa-Victor P, Baeza-Raja B, Jardí M, Bosch-Comas A, Esteller M, Caelles C, Serrano AL, Wagner EF, Muñoz-Cánoves P: Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38α in abrogating myoblast proliferation. EMBO J. 2007, 26: 1245-1256. 10.1038/sj.emboj.7601587.
Perdiguero E, Ruiz-Bonilla V, Serrano AL, Muñoz-Cánoves P: Genetic deficiency of p38α reveals its critical role in myoblast cell cycle exit: the p38α-JNK connection. Cell Cycle. 2007, 6: 1298-1303. 10.4161/cc.6.11.4315.
Ruiz-Bonilla V, Perdiguero E, Gresh L, Serrano AL, Zamora M, Sousa-Victor P, Jardí M, Wagner EF, Muñoz-Cánoves P: Efficient adult skeletal muscle regeneration in mice deficient in p38α, p38γ and p38δ MAP kinases. Cell Cycle. 2008, 7: 2208-2214. 10.4161/cc.7.14.6273.
Lechner C, Zahalka MA, Giot JF, Møller NP, Ullrich A: ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc Natl Acad Sci USA. 1996, 93: 4355-4359. 10.1073/pnas.93.9.4355.
Wang H, Xu Q, Xiao F, Jiang Y, Wu Z: Involvement of the p38 mitogen-activated protein kinase α, β, and γ isoforms in myogenic differentiation. Mol Biol Cell. 2008, 19: 1519-1528. 10.1091/mbc.E07-08-0817.
Takaesu G, Kang JS, Bae GU, Yi MJ, Lee CM, Reddy EP, Krauss RS: Activation of p38α/β MAPK in myogenesis via binding of the scaffold protein JLP to the cell surface protein Cdo. J Cell Biol. 2006, 175: 383-388. 10.1083/jcb.200608031.
Kang JS, Bae GU, Yi MJ, Yang YJ, Oh JE, Takaesu G, Zhou YT, Low BC, Krauss RS: A Cdo-Bnip-2-Cdc42 signaling pathway regulates p38α/β MAPK activity and myogenic differentiation. J Cell Biol. 2008, 182: 497-507. 10.1083/jcb.200801119.
Lu M, Krauss RS: N-cadherin ligation, but not Sonic hedgehog binding, initiates Cdo-dependent p38α/β MAPK signaling in skeletal myoblasts. Proc Natl Acad Sci USA. 2010, 107: 4212-4217. 10.1073/pnas.0908883107.
Bhatnagar S, Kumar A, Makonchuk DY, Li H, Kumar A: Transforming growth factor-β-activated kinase 1 is an essential regulator of myogenic differentiation. J Biol Chem. 2010, 285: 6401-6411. 10.1074/jbc.M109.064063.
Puri PL, Wu Z, Zhang P, Wood LD, Bhakta KS, Han J, Feramisco JR, Karin M, Wang JY: Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev. 2000, 14: 574-584.
Serra C, Palacios D, Mozzetta C, Forcales SV, Morantte I, Ripani M, Jones DR, Du K, Jhala US, Simone C, Puri PL: Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation. Mol Cell. 2007, 28: 200-213. 10.1016/j.molcel.2007.08.021.
Palacios D, Mozzetta C, Consalvi S, Caretti G, Saccone V, Proserpio V, Marquez VE, Valente S, Mai A, Forcales SV, Sartorelli V, Puri PL: TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell. 2010, 7: 455-469. 10.1016/j.stem.2010.08.013.
Simone C, Forcales SV, Hill DA, Imbalzano AN, Latella L, Puri PL: p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat Genet. 2004, 36: 738-743. 10.1038/ng1378.
Rampalli S, Li L, Mak E, Ge K, Brand M, Tapscott SJ, Dilworth FJ: p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation. Nat Struct Mol Biol. 2007, 14: 1150-1156. 10.1038/nsmb1316.
Lluís F, Ballestar E, Suelves M, Esteller M, Muñoz-Cánoves P: E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle-specific gene transcription. EMBO J. 2005, 24: 974-984. 10.1038/sj.emboj.7600528.
Baeza-Raja B, Muñoz-Cánoves P: p38 MAPK-induced nuclear factor-κΒ activity is required for skeletal muscle differentiation: role of interleukin-6. Mol Biol Cell. 2004, 15: 2013-2026. 10.1091/mbc.E03-08-0585.
Gonzalez I, Tripathi G, Carter EJ, Cobb LJ, Salih DAM, Lovett FA, Holding C, Pell JM: Akt2, a novel functional link between p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in myogenesis. Mol Cell Biol. 2004, 24: 3607-3622. 10.1128/MCB.24.9.3607-3622.2004.
Cabane C, Coldefy AS, Yeow K, Dérijard B: The p38 pathway regulates Akt both at the protein and transcriptional activation levels during myogenesis. Cell Signal. 2004, 16: 1405-1415. 10.1016/j.cellsig.2004.05.003.
Lovett FA, Cosgrove RA, Gonzalez I, Pell JM: Essential role for p38α MAPK but not p38γ MAPK in Igf2 expression and myoblast differentiation. Endocrinology. 2010, 151: 4368-4380. 10.1210/en.2010-0209.
Briata P, Forcales SV, Ponassi M, Corte G, Chen CY, Karin M, Puri PL, Gherzi R: p38-dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts. Mol Cell. 2005, 20: 891-903. 10.1016/j.molcel.2005.10.021.
Weston AD, Sampaio AV, Ridgeway AG, Underhill TM: Inhibition of p38 MAPK signaling promotes late stages of myogenesis. J Cell Sci. 2003, 116: 2885-2893. 10.1242/jcs.00525.
Staal SP: Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci USA. 1987, 84: 5034-5037. 10.1073/pnas.84.14.5034.
Coffer PJ, Woodgett JR: Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families. Eur J Biochem. 1991, 201: 475-481. 10.1111/j.1432-1033.1991.tb16305.x.
Bellacosa A, Testa JR, Staal SP, Tsichlis PN: A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science. 1991, 254: 274-277. 10.1126/science.1833819.
Jones PF, Jakubowicz T, Pitossi FJ, Maurer F, Hemmings BA: Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc Natl Acad Sci USA. 1991, 88: 4171-4175. 10.1073/pnas.88.10.4171.
Downward J: Signal transduction: a target for PI(3) kinase. Nature. 1995, 376: 553-554. 10.1038/376553a0.
Konishi H, Kuroda S, Tanaka M, Matsuzaki H, Ono Y, Kameyama K, Haga T, Kikkawa U: Molecular cloning and characterization of a new member of the RAC protein kinase family: association of the pleckstrin homology domain of three types of RAC protein kinase with protein kinase C subspecies and βγ subunits of G proteins. Biochem Biophys Res Commun. 1995, 216: 526-534. 10.1006/bbrc.1995.2654.
Glass DJ: Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol. 2003, 5: 87-90. 10.1038/ncb0203-87.
Franke TF: PI3K/Akt: getting it right matters. Oncogene. 2008, 27: 6473-6488. 10.1038/onc.2008.313.
Dong LQ, Liu F: PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle. Am J Physiol Endocrinol Metab. 2005, 289: E187-E196. 10.1152/ajpendo.00011.2005.
Elia D, Madhala D, Ardon E, Reshef R, Halevy O: Sonic hedgehog promotes proliferation and differentiation of adult muscle cells: involvement of MAPK/ERK and PI3K/Akt pathways. Biochim Biophys Acta. 2007, 1773: 1438-1446. 10.1016/j.bbamcr.2007.06.006.
Bae GU, Lee JR, Kim BG, Han JW, Leem YE, Lee HJ, Ho SM, Hahn MJ, Kang JS: Cdo interacts with APPL1 and activates Akt in myoblast differentiation. Mol Biol Cell. 2010, 21: 2399-2411. 10.1091/mbc.E09-12-1011.
Mao X, Kikani CK, Riojas RA, Langlais P, Wang L, Ramos FJ, Fang Q, Christ-Roberts CY, Hong JY, Kim RY, Liu F, Dong LQ: APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol. 2006, 8: 516-523. 10.1038/ncb1404.
Saito T, Jones CC, Huang S, Czech MP, Pilch PF: The interaction of Akt with APPL1 is required for insulin-stimulated Glut4 translocation. J Biol Chem. 2007, 282: 32280-32287. 10.1074/jbc.M704150200.
Florini JR, Magri KA, Ewton DZ, James PL, Grindstaff K, Rotwein PS: "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J Biol Chem. 1991, 266: 15917-15923.
Stewart CE, Rotwein P: Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J Biol Chem. 1996, 271: 11330-11338. 10.1074/jbc.271.19.11330.
Stewart CE, James PL, Fant ME, Rotwein P: Overexpression of insulin-like growth factor-II induces accelerated myoblast differentiation. J Cell Physiol. 1996, 169: 23-32. 10.1002/(SICI)1097-4652(199610)169:1<23::AID-JCP3>3.0.CO;2-G.
Musarò A, Rosenthal N: Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I. Mol Cell Biol. 1999, 19: 3115-3124.
Semsarian C, Sutrave P, Richmond DR, Graham RM: Insulin-like growth factor (IGF-I) induces myotube hypertrophy associated with an increase in anaerobic glycolysis in a clonal skeletal-muscle cell model. Biochem J. 1999, 339: 443-451. 10.1042/0264-6021:3390443.
Musarò A, McCullagh KJ, Naya FJ, Olson EN, Rosenthal N: IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature. 1999, 400: 581-585. 10.1038/23060.
Tureckova J, Wilson EM, Cappalonga JL, Rotwein P: Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J Biol Chem. 2001, 276: 39264-39270. 10.1074/jbc.M104991200.
Coleman ME, DeMayo F, Yin KC, Lee HM, Geske R, Montgomery C, Schwartz RJ: Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem. 1995, 270: 12109-12116. 10.1074/jbc.270.20.12109.
Barton-Davis ER, Shoturma DI, Musarò A, Rosenthal N, Sweeney HL: Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA. 1998, 95: 15603-15607. 10.1073/pnas.95.26.15603.
Musarò A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL, Rosenthal N: Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet. 2001, 27: 195-200. 10.1038/84839.
Fujio Y, Guo K, Mano T, Mitsuuchi Y, Testa JR, Walsh K: Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol Cell Biol. 1999, 19: 5073-5082.
Tamir Y, Bengal E: Phosphoinositide 3-kinase induces the transcriptional activity of MEF2 proteins during muscle differentiation. J Biol Chem. 2000, 275: 34424-34432.
Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD: Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol. 2001, 3: 1014-1019. 10.1038/ncb1101-1014.
Pallafacchina G, Calabria E, Serrano AL, Kalhovde JM, Schiaffino S: A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci USA. 2002, 99: 9213-9218. 10.1073/pnas.142166599.
Lai KMV, Gonzalez M, Poueymirou WT, Kline WO, Na E, Zlotchenko E, Stitt TN, Economides AN, Yancopoulos GD, Glass DJ: Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol. 2004, 24: 9295-9304. 10.1128/MCB.24.21.9295-9304.2004.
Vandromme M, Rochat A, Meier R, Carnac G, Besser D, Hemmings BA, Fernandez A, Lamb NJ: Protein kinase Bβ/Akt2 plays a specific role in muscle differentiation. J Biol Chem. 2001, 276: 8173-8179. 10.1074/jbc.M005587200.
Héron-Milhavet L, Franckhauser C, Rana V, Berthenet C, Fisher D, Hemmings BA, Fernandez A, Lamb NJC: Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding. Mol Cell Biol. 2006, 26: 8267-8280. 10.1128/MCB.00201-06.
Altomare DA, Guo K, Cheng JQ, Sonoda G, Walsh K, Testa JR: Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene. Oncogene. 1995, 11: 1055-1060.
Altomare DA, Lyons GE, Mitsuuchi Y, Cheng JQ, Testa JR: Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin. Oncogene. 1998, 16: 2407-2411. 10.1038/sj.onc.1201750.
Calera MR, Pilch PF: Induction of Akt-2 correlates with differentiation in Sol8 muscle cells. Biochem Biophys Res Commun. 1998, 251: 835-841. 10.1006/bbrc.1998.9566.
Kaneko S, Feldman RI, Yu L, Wu Z, Gritsko T, Shelley SA, Nicosia SV, Nobori T, Cheng JQ: Positive feedback regulation between Akt2 and MyoD during muscle differentiation: cloning of Akt2 promoter. J Biol Chem. 2002, 277: 23230-23235. 10.1074/jbc.M201733200.
Rochat A, Fernandez A, Vandromme M, Molès JP, Bouschet T, Carnac G, Lamb NJC: Insulin and wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy. Mol Biol Cell. 2004, 15: 4544-4555. 10.1091/mbc.E03-11-0816.
Héron-Milhavet L, Mamaeva D, Rochat A, Lamb NJC, Fernandez A: Akt2 is implicated in skeletal muscle differentiation and specifically binds Prohibitin2/REA. J Cell Physiol. 2008, 214: 158-165. 10.1002/jcp.21177.
Sumitani S, Goya K, Testa JR, Kouhara H, Kasayama S: Akt1 and Akt2 differently regulate muscle creatine kinase and myogenin gene transcription in insulin-induced differentiation of C2C12 myoblasts. Endocrinology. 2002, 143: 820-828. 10.1210/en.143.3.820.
Rosenthal SM, Cheng ZQ: Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts. Proc Natl Acad Sci USA. 1995, 92: 10307-10311. 10.1073/pnas.92.22.10307.
Engert JC, Berglund EB, Rosenthal N: Proliferation precedes differentiation in IGF-I-stimulated myogenesis. J Cell Biol. 1996, 135: 431-440. 10.1083/jcb.135.2.431.
Machida S, Spangenburg EE, Booth FW: Forkhead transcription factor FoxO1 transduces insulin-like growth factor's signal to p27Kip1 in primary skeletal muscle satellite cells. J Cell Physiol. 2003, 196: 523-531. 10.1002/jcp.10339.
Viñals F, Pouysségur J: Confluence of vascular endothelial cells induces cell cycle exit by inhibiting p42/p44 mitogen-activated protein kinase activity. Mol Cell Biol. 1999, 19: 2763-2772.
Suzuki E, Nagata D, Yoshizumi M, Kakoki M, Goto A, Omata M, Hirata Y: Reentry into the cell cycle of contact-inhibited vascular endothelial cells by a phosphatase inhibitor: possible involvement of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem. 2000, 275: 3637-3644. 10.1074/jbc.275.5.3637.
Jacobsen K, Groth A, Willumsen BM: Ras-inducible immortalized fibroblasts: focus formation without cell cycle deregulation. Oncogene. 2002, 21: 3058-3067. 10.1038/sj.onc.1205423.
Zhang L, Bewick M, Lafrenie RM: Role of Raf-1 and FAK in cell density-dependent regulation of integrin-dependent activation of MAP kinase. Carcinogenesis. 2002, 23: 1251-1258. 10.1093/carcin/23.7.1251.
Gherzi R, Trabucchi M, Ponassi M, Gallouzi IE, Rosenfeld MG, Briata P: Akt2-mediated phosphorylation of Pitx2 controls Ccnd1 mRNA decay during muscle cell differentiation. Cell Death Differ. 2010, 17: 975-983. 10.1038/cdd.2009.194.
Hribal ML, Nakae J, Kitamura T, Shutter JR, Accili D: Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors. J Cell Biol. 2003, 162: 535-541. 10.1083/jcb.200212107.
Xu Q, Wu Z: The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells. J Biol Chem. 2000, 275: 36750-36757. 10.1074/jbc.M005030200.
Cabane C, Coldefy AS, Yeow K, Dérijard B: The p38 pathway regulates Akt both at the protein and transcriptional activation levels during myogenesis. Cell Signal. 2004, 16: 1405-1415. 10.1016/j.cellsig.2004.05.003.
van der Velden JLJ, Langen RCJ, Kelders MCJM, Wouters EFM, Janssen-Heininger YMW, Schols AMWJ: Inhibition of glycogen synthase kinase-3β activity is sufficient to stimulate myogenic differentiation. Am J Physiol Cell Physiol. 2006, 290: C453-C462.
van der Velden JLJ, Schols AMWJ, Willems J, Kelders MCJM, Langen RCJ: Glycogen synthase kinase 3 suppresses myogenic differentiation through negative regulation of NFATc3. J Biol Chem. 2008, 283: 358-366.
Pansters NAM, van der Velden JLJ, Kelders MCJM, Laeremans H, Schols AMWJ, Langen RCJ: Segregation of myoblast fusion and muscle-specific gene expression by distinct ligand-dependent inactivation of GSK-3β. Cell Mol Life Sci. 2011, 68: 523-535. 10.1007/s00018-010-0467-7.
Wilson EM, Tureckova J, Rotwein P: Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation. Mol Biol Cell. 2004, 15: 497-505.
Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ: Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol. 2001, 3: 1009-1013. 10.1038/ncb1101-1009.
Vyas DR, Spangenburg EE, Abraha TW, Childs TE, Booth FW: GSK-3β negatively regulates skeletal myotube hypertrophy. Am J Physiol Cell Physiol. 2002, 283: C545-C551.
Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL: Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 2004, 117: 399-412. 10.1016/S0092-8674(04)00400-3.
Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ: The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell. 2004, 14: 395-403. 10.1016/S1097-2765(04)00211-4.
Park IH, Erbay E, Nuzzi P, Chen J: Skeletal myocyte hypertrophy requires mTOR kinase activity and S6K1. Exp Cell Res. 2005, 309: 211-219. 10.1016/j.yexcr.2005.05.017.
Erbay E, Chen J: The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. J Biol Chem. 2001, 276: 36079-36082. 10.1074/jbc.C100406200.
Shu L, Zhang X, Houghton PJ: Myogenic differentiation is dependent on both the kinase function and the N-terminal sequence of mammalian target of rapamycin. J Biol Chem. 2002, 277: 16726-16732. 10.1074/jbc.M112285200.
Erbay E, Park IH, Nuzzi PD, Schoenherr CJ, Chen J: IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients. J Cell Biol. 2003, 163: 931-936. 10.1083/jcb.200307158.
Shu L, Houghton PJ: The mTORC2 complex regulates terminal differentiation of C2C12 myoblasts. Mol Cell Biol. 2009, 29: 4691-4700. 10.1128/MCB.00764-09.
Ge Y, Wu AL, Warnes C, Liu J, Zhang C, Kawasome H, Terada N, Boppart MD, Schoenherr CJ, Chen J: mTOR regulates skeletal muscle regeneration in vivo through kinase-dependent and kinase-independent mechanisms. Am J Physiol Cell Physiol. 2009, 297: C1434-C1444. 10.1152/ajpcell.00248.2009.
Latres E, Amini AR, Amini AA, Griffiths J, Martin FJ, Wei Y, Lin HC, Yancopoulos GD, Glass DJ: Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem. 2005, 280: 2737-2744.
Ohanna M, Sobering AK, Lapointe T, Lorenzo L, Praud C, Petroulakis E, Sonenberg N, Kelly PA, Sotiropoulos A, Pende M: Atrophy of S6K1-/- skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat Cell Biol. 2005, 7: 286-294. 10.1038/ncb1231.
Sun Y, Ge Y, Drnevich J, Zhao Y, Band M, Chen J: Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis. J Cell Biol. 2010, 189: 1157-1169. 10.1083/jcb.200912093.
Allen RE, Sheehan SM, Taylor RG, Kendall TL, Rice GM: Hepatocyte growth factor activates quiescent skeletal muscle satellite cells in vitro. J Cell Physiol. 1995, 165: 307-312. 10.1002/jcp.1041650211.
Tatsumi R, Anderson JE, Nevoret CJ, Halevy O, Allen RE: HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev Biol. 1998, 194: 114-128. 10.1006/dbio.1997.8803.
Miller KJ, Thaloor D, Matteson S, Pavlath GK: Hepatocyte growth factor affects satellite cell activation and differentiation in regenerating skeletal muscle. Am J Physiol Cell Physiol. 2000, 278: C174-C181.
Sun L, Ma K, Wang H, Xiao F, Gao Y, Zhang W, Wang K, Gao X, Ip N, Wu Z: JAK1-STAT1-STAT3, a key pathway promoting proliferation and preventing premature differentiation of myoblasts. J Cell Biol. 2007, 179: 129-138. 10.1083/jcb.200703184.
Gillespie MA, Le Grand F, Scimè A, Kuang S, von Maltzahn J, Seale V, Cuenda A, Ranish JA, Rudnicki MA: p38-γ-dependent gene silencing restricts entry into the myogenic differentiation program. J Cell Biol. 2009, 187: 991-1005. 10.1083/jcb.200907037.
Nishiyama T, Kii I, Kudo A: Inactivation of Rho/ROCK signaling is crucial for the nuclear accumulation of FKHR and myoblast fusion. J Biol Chem. 2004, 279: 47311-47319. 10.1074/jbc.M403546200.
Castellani L, Salvati E, Alemà S, Falcone G: Fine regulation of RhoA and Rock is required for skeletal muscle differentiation. J Biol Chem. 2006, 281: 15249-15257. 10.1074/jbc.M601390200.
Lim MJ, Choi KJ, Ding Y, Kim JH, Kim BS, Kim YH, Lee J, Choe W, Kang I, Ha J, Yoon KS, Kim SS: RhoA/Rho kinase blocks muscle differentiation via serine phosphorylation of insulin receptor substrate-1 and -2. Mol Endocrinol. 2007, 21: 2282-2293. 10.1210/me.2007-0114.
Bae GU, Kim BG, Lee HJ, Oh JE, Lee SJ, Zhang W, Krauss RS, Kang JS: Cdo binds Abl to promote p38α/β mitogen-activated protein kinase activity and myogenic differentiation. Mol Cell Biol. 2009, 29: 4130-4143. 10.1128/MCB.00199-09.
di Bari MG, Ciuffini L, Mingardi M, Testi R, Soddu S, Barilà D: c-Abl acetylation by histone acetyltransferases regulates its nuclear-cytoplasmic localization. EMBO Rep. 2006, 7: 727-733. 10.1038/sj.embor.7400700.
Lu J, McKinsey TA, Zhang CL, Olson EN: Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell. 2000, 6: 233-244. 10.1016/S1097-2765(00)00025-3.
McKinsey TA, Zhang CL, Olson EN: Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc Natl Acad Sci USA. 2000, 97: 14400-14405. 10.1073/pnas.260501497.
McKinsey TA, Zhang CL, Lu J, Olson EN: Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature. 2000, 408: 106-111. 10.1038/35040593.
Xu Q, Yu L, Liu L, Cheung CF, Li X, Yee SP, Yang XJ, Wu Z: p38 mitogen-activated protein kinase-, calcium-calmodulin-dependent protein kinase-, and calcineurin-mediated signaling pathways transcriptionally regulate myogenin expression. Mol Biol Cell. 2002, 13: 1940-1952. 10.1091/mbc.02-02-0016.
Deng X, Ewton DZ, Pawlikowski B, Maimone M, Friedman E: Mirk/dyrk1B is a Rho-induced kinase active in skeletal muscle differentiation. J Biol Chem. 2003, 278: 41347-41354. 10.1074/jbc.M306780200.
Deng X, Ewton DZ, Mercer SE, Friedman E: Mirk/dyrk1B decreases the nuclear accumulation of class II histone deacetylases during skeletal muscle differentiation. J Biol Chem. 2005, 280: 4894-4905.
Dinev D, Jordan BW, Neufeld B, Lee JD, Lindemann D, Rapp UR, Ludwig S: Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells. EMBO Rep. 2001, 2: 829-834. 10.1093/embo-reports/kve177.
Carter EJ, Cosgrove RA, Gonzalez I, Eisemann JH, Lovett FA, Cobb LJ, Pell JM: MEK5 and ERK5 are mediators of the pro-myogenic actions of IGF-2. J Cell Sci. 2009, 122: 3104-3112. 10.1242/jcs.045757.
Wang K, Wang C, Xiao F, Wang H, Wu Z: JAK2/STAT2/STAT3 are required for myogenic differentiation. J Biol Chem. 2008, 283: 34029-34036. 10.1074/jbc.M803012200.
Kleger A, Loebnitz C, Pusapati GV, Armacki M, Müller M, Tümpel S, Illing A, Hartmann D, Brunner C, Liebau S, Rudolph KL, Adler G, Seufferlein T: Protein kinase D2 is an essential regulator of murine myoblast differentiation. PLoS One. 2011, 6: e14599-10.1371/journal.pone.0014599.
Bois PRJ, Brochard VF, Salin-Cantegrel AVA, Cleveland JL, Grosveld GC: FoxO1a-cyclic GMP-dependent kinase I interactions orchestrate myoblast fusion. Mol Cell Biol. 2005, 25: 7645-7656. 10.1128/MCB.25.17.7645-7656.2005.
Madaro L, Marrocco V, Fiore P, Aulino P, Smeriglio P, Adamo S, Molinaro M, Bouché M: PKCθ signaling is required for myoblast fusion by regulating the expression of caveolin-3 and β1D integrin upstream focal adhesion kinase. Mol Biol Cell. 2011, 22: 1409-1419. 10.1091/mbc.E10-10-0821.
Quach NL, Biressi S, Reichardt LF, Keller C, Rando TA: Focal adhesion kinase signaling regulates the expression of caveolin 3 and β1 integrin, genes essential for normal myoblast fusion. Mol Biol Cell. 2009, 20: 3422-3435. 10.1091/mbc.E09-02-0175.
Pelosi M, Marampon F, Zani BM, Prudente S, Perlas E, Caputo V, Cianetti L, Berno V, Narumiya S, Kang SW, Musarò A, Rosenthal N: ROCK2 and its alternatively spliced isoform ROCK2m positively control the maturation of the myogenic program. Mol Cell Biol. 2007, 27: 6163-6176. 10.1128/MCB.01735-06.